Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
<p>This is the protocol for a review and there is no abstract. The objectives are as follows:</p><p>To determine the efficacy and safety of anti-fibrinolytics (lysine analogues) in preventing bleeding in patients with haematological disorders.</p>
Κύριοι συγγραφείς: | Wardrop, D, Estcourt, L, Doree, C, Hopewell, S, Brunskill, S, Stanworth, S, Murphy, M |
---|---|
Μορφή: | Journal article |
Έκδοση: |
Cochrane Collaboration
2016
|
Παρόμοια τεκμήρια
-
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
ανά: Estcourt, L, κ.ά.
Έκδοση: (2016) -
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
ανά: Wardrop, D, κ.ά.
Έκδοση: (2013) -
Pathogen-reduced platelets for the prevention of bleeding (protocol)
ανά: Butler, C, κ.ά.
Έκδοση: (2011) -
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
ανά: Estcourt, L, κ.ά.
Έκδοση: (2012) -
Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
ανά: Estcourt, L, κ.ά.
Έκδοση: (2014)